Xeris Biopharma Inc.

4.16
-0.22 (-5.02%)
At close: Apr 16, 2025, 11:31 AM

Xeris Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
203.07M 163.91M 110.25M 110.25M 49.59M 20.16M 2.46M 1.56M 1.07M
36.83M 28.64M 22.63M 22.63M 13.32M 9.33M 42K 4K 8K
166.24M 135.27M 87.61M 87.61M 36.27M 10.83M 2.42M 1.55M 1.07M
-33.65M -44.01M -81.94M -81.94M -115.16M -83.55M -59.34M -26.63M -13.23M
5.32M 4.75M 2.58M 2.58M 313K 2.96M 1.61M 124K 5K
-57.1M -63.5M -96.08M -96.08M -122.72M -91.25M -60.08M -26.55M -13.21M
-54.84M -62.26M -94.66M -94.66M -122.72M -91.14M -60.08M -26.55M -13.21M
163.48M 146.09M 137.75M 137.75M 125.72M 73.73M 21.11M 8.02M 4.06M
25.56M 22.34M 20.97M 20.97M 25.16M 20.92M 40.65M 20.17M 10.24M
10.84M 10.84M -14.14M 10.84M 550K -280K n/a -1K -5K
199.88M 179.28M 169.55M 169.55M 151.43M 94.37M 61.77M 28.18M 14.3M
30.48M 26.61M 15.32M 15.32M 7.18M 10.66M 2.54M 2K 2K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
236.72M 207.92M 192.19M 192.19M 164.75M 103.7M 61.81M 28.18M 14.31M
-2.27M -1.25M -1.42M -1.42M -110K -110K 1.81M 1K -3K
146.77M 137.67M 135.63M 79.03M 42.64M 26.11M 12.05M 2.03M 1.84M
146.77M 137.67M 135.63M 79.03M 42.64M 26.11M 12.05M 2.03M 1.84M
-0.37 -0.45 -0.7 -1.2 -2.88 -3.49 -4.99 -13.09 -7.17
-0.37 -0.45 -0.7 -1.2 -2.88 -3.49 -4.99 -13.09 -7.17
-13.99M -23.73M -69.31M -113.67M -80.08M -117.8M -57.22M -26.38M -13.09M
-26.62M -36.9M -81.98M -115.55M -80.59M -118.88M -57.53M -26.55M -13.21M
12.63M 13.16M 12.67M 1.88M 1.47M 1.08M 320K 177K 116K